Terms: = Lymphoma AND MALT1, ENSG00000172175, 10892 AND Treatment
131 results:
1. Blood malt1 expression could help predict treatment outcomes in psoriasis patients, especially in those receiving biologics.
Liu Q; Zhang Y; Xu B; Jin X; Yang T; Fan L
Immun Inflamm Dis; 2024 Apr; 12(4):e1235. PubMed ID: 38578002
[TBL] [Abstract] [Full Text] [Related]
2. Development of Potent malt1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-
Liang X; Yu H; Liang R; Feng Z; Saidahmatov A; Sun C; Ren H; Wei X; Zhao J; Yang C; Liu H
J Med Chem; 2024 Feb; 67(4):2884-2906. PubMed ID: 38349664
[TBL] [Abstract] [Full Text] [Related]
3. Primary central nervous system marginal zone lymphoma.
Flospergher E; Marino F; Calimeri T; Cangi MG; Ferreri AJM; Ponzoni M; Bongiovanni L
Br J Haematol; 2024 Jan; 204(1):31-44. PubMed ID: 38054330
[TBL] [Abstract] [Full Text] [Related]
4. malt1 Positively Relates to T Helper 1 and T Helper 17 cells, and Serves as a Potential Biomarker for Predicting 30-Day Mortality in Stanford Type A Aortic Dissection Patients.
Zong J; Yang L; Wei L; Wang D; Wang X; Zhang Z
Tohoku J Exp Med; 2023 Dec; 261(4):299-307. PubMed ID: 37704417
[TBL] [Abstract] [Full Text] [Related]
5. Proteolytic Activity of the Paracaspase malt1 Is Involved in Epithelial Restitution and Mucosal Healing.
Wittner L; Wagener L; Wiese JJ; Stolzer I; Krug SM; Naschberger E; Jackstadt R; Beyaert R; Atreya R; Kühl AA; Sturm G; Gonzalez-Acera M; Patankar JV; Becker C; Siegmund B; Trajanoski Z; Winner B; Neurath MF; Schumann M; Günther C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108564
[TBL] [Abstract] [Full Text] [Related]
6. Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-B Signaling.
Sato T; Maeta T; Ito S
Anticancer Res; 2023 May; 43(5):1901-1908. PubMed ID: 37097671
[TBL] [Abstract] [Full Text] [Related]
7. malt1 paracaspase is overexpressed in hepatocellular carcinoma and promotes cancer cell survival and growth.
Kurden-Pekmezci A; Cakiroglu E; Eris S; Mazi FA; Coskun-Deniz OS; Dalgic E; Oz O; Senturk S
Life Sci; 2023 Jun; 323():121690. PubMed ID: 37059355
[TBL] [Abstract] [Full Text] [Related]
8. Localization and expression profiles of gingival monocyte chemoattractant protein-1-induced protein-1 (MCPIP-1) and mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT-1).
Yu L; Firatli Y; Elmanfi S; Gürsoy M; Özdemir Kabalak M; Kasnak G; Pussinen P; Bikker FJ; Caglayan F; Firatli E; Gürsoy UK
Clin Oral Investig; 2023 May; 27(5):2065-2074. PubMed ID: 37010640
[TBL] [Abstract] [Full Text] [Related]
9. Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of malt1 inhibitors in B-cell lymphomas.
Shah SB; Carlson CR; Lai K; Zhong Z; Marsico G; Lee KM; Félix Vélez NE; Abeles EB; Allam M; Hu T; Walter LD; Martin KE; Gandhi K; Butler SD; Puri R; McCleary-Wheeler AL; Tam W; Elemento O; Takata K; Steidl C; Scott DW; Fontan L; Ueno H; Cosgrove BD; Inghirami G; García AJ; Coskun AF; Koff JL; Melnick A; Singh A
Nat Mater; 2023 Apr; 22(4):511-523. PubMed ID: 36928381
[TBL] [Abstract] [Full Text] [Related]
10. Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating malt1-NF-𝜅B-IL-6 axis of tumor-associated macrophages.
Zhou B; Mo Z; Lai G; Chen X; Li R; Wu R; Zhu J; Zheng F
J Exp Clin Cancer Res; 2023 Feb; 42(1):48. PubMed ID: 36797769
[TBL] [Abstract] [Full Text] [Related]
11. Cotargeting of BTK and malt1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.
Jiang VC; Liu Y; Lian J; Huang S; Jordan A; Cai Q; Lin R; Yan F; McIntosh J; Li Y; Che Y; Chen Z; Vargas J; Badillo M; Bigcal JN; Lee HH; Wang W; Yao Y; Nie L; Flowers CR; Wang M
J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719376
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT lymphoma in Koreans: A Single Center Retrospective Analysis].
Jung H; Shin DW; Cheung DY; Lee HH; Kim JI; Park SH; Kim TJ
Korean J Gastroenterol; 2023 Jan; 81(1):29-35. PubMed ID: 36695064
[TBL] [Abstract] [Full Text] [Related]
13. Blood malt1 deficiency is common and relates to unfavorable induction therapy response and survival profile in acute myeloid leukemia patients.
Geng H; Wang Y; Wang S
Hematology; 2022 Dec; 27(1):1176-1183. PubMed ID: 36314929
[TBL] [Abstract] [Full Text] [Related]
14. malt1 reflects inflammatory cytokines, disease activity, and its chronological change could estimate treatment response to infliximab in Crohn's disease patients.
Dong X; Chen X; Ren Y
J Clin Lab Anal; 2022 Oct; 36(10):e24650. PubMed ID: 36036788
[TBL] [Abstract] [Full Text] [Related]
15. malt1 regulates Th2 and Th17 differentiation
Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
Front Immunol; 2022; 13():913830. PubMed ID: 35967391
[TBL] [Abstract] [Full Text] [Related]
16. Extranodal MALT lymphoma in the Oral Cavity: A Series of Three Cases with Review of Literature.
Kaur R; Shetty D; Bagal BP; Gujral S; Sengar M; Laskar S; Nayak L; Shet T
Head Neck Pathol; 2022 Dec; 16(4):1242-1250. PubMed ID: 35674932
[TBL] [Abstract] [Full Text] [Related]
17. malt1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.
Yuan J; Xiang L; Wang F; Zhang L; Liu G; Chang X; Zhang A; Tao Y
J Clin Lab Anal; 2022 Jul; 36(7):e24472. PubMed ID: 35622982
[TBL] [Abstract] [Full Text] [Related]
18. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors.
Wang F; Liu G; Xiang L; Yuan J; Tao Y; Zhang L; Zhang A; Chang X
J Clin Lab Anal; 2022 Jun; 36(6):e24449. PubMed ID: 35500150
[TBL] [Abstract] [Full Text] [Related]
19. Investigation of endoscopic findings in nine cases of Helicobacter suis-infected gastritis complicated by gastric mucosa-associated lymphoid tissue lymphoma.
Kadota H; Yuge R; Miyamoto R; Otani R; Takigawa H; Hayashi R; Urabe Y; Oka S; Sentani K; Oue N; Kitadai Y; Tanaka S
Helicobacter; 2022 Jun; 27(3):e12887. PubMed ID: 35363918
[TBL] [Abstract] [Full Text] [Related]
20. Expanding the Clinical and Immunological Phenotypes and Natural History of malt1 Deficiency.
Sefer AP; Abolhassani H; Ober F; Kayaoglu B; Bilgic Eltan S; Kara A; Erman B; Surucu Yilmaz N; Aydogmus C; Aydemir S; Charbonnier LM; Kolukisa B; Azizi G; Delavari S; Momen T; Aliyeva S; Kendir Demirkol Y; Tekin S; Kiykim A; Baser OF; Cokugras H; Gursel M; Karakoc-Aydiner E; Ozen A; Krappmann D; Chatila TA; Rezaei N; Baris S
J Clin Immunol; 2022 Apr; 42(3):634-652. PubMed ID: 35079916
[TBL] [Abstract] [Full Text] [Related]
[Next]
